Taking the potential harms of psychedelic-assisted therapy seriously: How do we prevent or mitigate the risks to vulnerable patients?
Int J Drug Policy July 26, 2024 Sharon R. Sznitman, Barbara Broers, Reto Auer et al. 1 citation
The article argues that the potential harms of psychedelic-assisted therapy must be taken seriously, focusing on how to prevent or mitigate risks to vulnerable patients. It discusses the need for robust safety protocols, clinical safeguards, and best practices to protect patient well-being. The authors emphasize that without careful risk management and harm reduction strategies, vulnerable individuals may face adverse outcomes. The work calls for integrating patient protection measures into therapeutic protocols and treatment standards to ensure safe clinical practice in psychedelic medicine.